Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares OutstandingWages, Salaries and Other
Ratios

AC Immune (ACIU) Depreciation Expense: 2019-2025

Historic Depreciation Expense for AC Immune (ACIU) over the last 7 years, with Sep 2025 value amounting to $341,270.

  • AC Immune's Depreciation Expense rose 73.93% to $341,270 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 55.23%. This contributed to the annual value of $557,023 for FY2021, which is 16.57% up from last year.
  • AC Immune's Depreciation Expense amounted to $341,270 in Q3 2025, which was up 8.67% from $314,051 recorded in Q2 2025.
  • AC Immune's 5-year Depreciation Expense high stood at $341,270 for Q3 2025, and its period low was $118,348 during Q1 2021.
  • In the last 3 years, AC Immune's Depreciation Expense had a median value of $191,329 in 2024 and averaged $217,422.
  • In the last 5 years, AC Immune's Depreciation Expense declined by 4.43% in 2023 and then soared by 73.93% in 2025.
  • Quarterly analysis of 5 years shows AC Immune's Depreciation Expense stood at $153,999 in 2021, then declined by 4.25% to $147,035 in 2022, then increased by 4.72% to $153,973 in 2023, then increased by 27.44% to $196,215 in 2024, then surged by 73.93% to $341,270 in 2025.
  • Its Depreciation Expense was $341,270 in Q3 2025, compared to $314,051 in Q2 2025 and $279,175 in Q1 2025.